Open access · CC-BY
via OpenAlex
The success-failure inversion in modern medicine
Madhur Mangalam, Jessica Fabianiak, Barry Cense
Frontiers in Public Health · 2026
Abstract
Twentieth-century medicine was most successful against diseases sharing a particular causal architecture: a discrete lesion standing in a relation of approximate necessity and sufficiency to a clinical syndrome, amenable to specific perturbation. Mortality from acute myocardial infarction has fallen by nearly 90 percent in the United States since 1970; pediatric leukemia has become survivable; HIV has become chronic. That success has shifted the residual burden toward conditions with a different architecture—late-life neurodegeneration, multimorbidity, frailty, idiopathic neuropathy—in which pathology is distributed across scales, and no single node carries the necessity that targeted intervention requires. The failure is not that medicine has extended life. It is that biomedical institutions have not adapted to the forms of vulnerability that accompany longer lives, and the non-adaptation is structural rather than accidental. This paper asks why: why funding and evaluation systems systematically favor research on discrete diseases and individual molecular targets over integrated research on aging as a systemic, multiscale, temporally extended process. We distinguish two levels at which the apparatus fragments its object. First-order fragmentation partitions aging into separately funded age-related diseases. Second-order fragmentation partitions aging itself into hallmarks, pathways, and targets pursued independently—which is why geroscience, the framework formulated to unify the age-related diseases, is decomposed by the apparatus that funds it. We specify the funding signatures each level of fragmentation predicts—across award duration, award mechanism, intervention modality, and the ratio of disease-specific to process-directed funding—and identify the data that would test them; we distinguish the several senses of reductionism at issue, defending integrative explanatory pluralism rather than holism; and we assess whether the hallmarks framework supports integration or licenses a longer list of targets. The argument is that the conceptual case for a multiscale account of late-life disease has been adequately made, and what remains unbuilt is institutional.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fpubh.2026.1932205
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Mangalam, M., Fabianiak, J., & Cense, B. (2026). The success-failure inversion in modern medicine. <em>Frontiers in Public Health</em>. https://doi.org/10.3389/fpubh.2026.1932205
Vancouver
Mangalam M, Fabianiak J, Cense B. The success-failure inversion in modern medicine. Frontiers in Public Health. 2026. doi:10.3389/fpubh.2026.1932205.
BibTeX
@article{madhur2026Thesuc,
title = {The success-failure inversion in modern medicine},
author = {Madhur Mangalam and Jessica Fabianiak and Barry Cense},
journal = {Frontiers in Public Health},
year = {2026},
doi = {10.3389/fpubh.2026.1932205},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in public health 2026
Open access · OA
The success-failure inversion in modern medicine.
Acta Biochimica Polonica 2007
Open access · CC-BY
Oxidative damage to DNA and antioxidant status in aging and age-related diseases.
Frontiers in Neurology 2023
Open access · CC-BY
Mechanisms and effects of metformin on skeletal muscle disorders
Redox Biology 2016
Open access · CC-BY
Redox mechanisms in age-related lung fibrosis
Nature Aging 2022
Open access · CC-BY
A complex systems approach to aging biology
Annual Review of Biomedical Data Science 2024
Open access · CC-BY